knowledge -WSS

knowledge

author：explore 2025-09-28 00:50:07 - browse：26752

Adobe

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available a novel treatment for a deadly condition that’s long been challenging to treat.

In a large trial published last year, the drug, called sotatercept, exceeded expectations in significantly increasing the distance that patients could walk and cutting the risk that their condition would worsen, that they would die, and that they would need new treatments.

Pulmonary arterial hypertension, or PAH, is estimated to occur in 15 to 50 per million people, mostly in women. It’s characterized by a proliferation of cells in the blood vessels that connect the right side of heart to the lungs, making it harder for blood to pass through and leading the heart to have to work harder to pump blood into the lungs. The disease, which causes difficulty breathing, fatigue and dizziness, has a high mortality rate, with one study finding that one-fifth of patients died at around three years after diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Lack of health data on LGBTQ+ people has serious consequences

WSS

Abortion clinic in Cancun will cater to Americans

Streamlined flu vaccines recommended by FDA advisory panel

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Sanofi CEO defends move to abandon profit guidance, boost research

The public health thinking behind the CDC’s new Covid guidance

FDA approves potent Eli Lilly obesity drug, Zepbound

hotspot

knowledge

hotspot

Heart attack and stroke risk calculators need revising

FDA approves potent Eli Lilly obesity drug, Zepbound

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Diversify hospital leadership teams to protect BIPOC patient health

Anesthesiologist group: stop taking Ozempic before surgery

Medicare drug price negotiation hearing pits pharma v Biden admin

Psychedelics group wrestles with new pharma identity

Victims of gun violence feel impacts long after bullet wound

Affirmative action in medical school literally saved lives

A clever new way to fix Medicaid and graduate medical education

knowledge

Change Healthcare: What is it, why does its cyberattack matter?

A new approach to psychiatric drug development

Sanofi CEO defends move to abandon profit guidance, boost research

For AI in health care standards, federal regulators join with industry group

The Sacklers, horror, and ‘The Fall of the House of Usher’

UCSF medical school apologizes for unethical prisoner experiments

hotspot

hotspot

explore

Wikipedia